Skip to main content

Breast Cancer Research and Treatment

Ausgabe 2/2024

Inhalt (20 Artikel)

Open Access Preclinical study

Current use of drains and management of seroma following mastectomy and axillary surgery: results of a United Kingdom national practice survey

K. Fairhurst, K. Roberts, P. Fairbrother, S. Potter, Nick Abbott, Raj Achuthan, Goran Ahmed, Rachel Ainsworth, Laura Arthur, Salena Bains, Zoe Barber, Jeremy Batt, Ashleigh Bell, Jane Carter, Alice Chambers, Anna Conway, Carol-Ann Courtney, Ian Daltrey, Raouf Daoud, Isabella Dash, Rajiv Dave, Julia Dicks, Urszula Donigiewicz, Hiba Fatayer, Daniel Glassman, Nikki Green, Eleanor Gutteridge, Ahmed Hamad, Anita Hargreaves, James Harvey, Shaziya Hassan Ali, Sophie Helme, Julia Henderson, Susan Hignett, Fiona Hoar, Jonathan Horsnell, Thomas Hubbard, Alex Humphreys, Javeria Iqbal, Omotayo Johnson, Meera Joshi, Charlotte Kallaway, Isabella Karat, Baek Kim, Eleftheria Kleidi, Manish Kothari, Chrissie Laban, Kelly Lambert, Siobhan Laws, Alexander Leeper, Serena Ledwidge, Valentina Lefemine, Jonathan Lund, E Jane Macaskill, Mariam Malik, James Mansell, Loaie Maraqa, Yazan Masannat, Julia Massey, Ross McLean, Jennifer McIlhenny, Colin Mcllmunn, Louise Merker, Geraldine Mitchell, Jo Mondani, Elizabeth Morrow, Nabila Nasir, Olubunmi Odofin, Caroline Osborne, Polly Partlett, Anna Powell-Chandler, Sreekumar Sundara Rajan, Clare Rogers, Chandeena Roshanlall, Matthew Philip Rowland, Walid Abou Samra, Lucy Satherley, Brendan Skelly, Richard Sutton, Anne Tansley, Marios Konstantinos Tasoulis, Simon Timbrel, Nader Touqan, Alison Waterworth, Lisa Whisker, Kate Williams, Nihal Gonen Yildirim, Charles Zammit

Open Access Clinical trial

A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer

Ozge Gumusay, Laura A. Huppert, Mark Jesus M. Magbanua, Chiara A. Wabl, Michael Assefa, Amy Jo Chien, Michelle E. Melisko, Melanie C. Majure, Mark Moasser, John Park, Hope S. Rugo

Clinical trial

Quantitative assessment of breast volume changes after whole-breast irradiation for breast cancer using breast auto-segmentation

Tae Hoon Lee, Sang Hee Ahn, Kwangzoo Chung, Won Park, Won Kyung Cho, Nalee Kim, Tae Gyu Kim, Haeyoung Kim

Clinical trial

Breast cancer outcomes based on method of detection in community-based breast cancer registry

Debbie Lee Bennett, Andrea Marie Winter, Laura Billadello, Mary Catherine Lowdermilk, Christina Michelle Doherty, Sakina Kazmi, Sydney Laster, Noor Al-Hammadi, Anna Hardy, Daniel B. Kopans, Linda Moy

Clinical trial

Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer

Takayuki Iwamoto, Naoki Niikura, Kenichi Watanabe, Takashi Takeshita, Yuichiro Kikawa, Kokoro Kobayashi, Nobutaka Iwakuma, Takuho Okamura, Hiroshi Tada, Shinji Ozaki, Toshitaka Okuno, Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Saji

Open Access Epidemiology

The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB)

Harriet T Rothschild, Elle N Clelland, Mary Kathryn Abel, A Jo Chien, Amy M Shui, Laura Esserman, Seema A Khan, Rita A Mukhtar

Epidemiology

Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer

Walter Carbajal-Ochoa, Daniela C. Bravo-Solarte, Ana M. Bernal, Jesus D. Anampa

Open Access Epidemiology

Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients

Stephanie Gu, Stephen Dusza, Elizabeth Quigley, Helen Haliasos, Alina Markova, Michael Marchetti, Andrea P. Moy, Chau Dang, Shanu Modi, Diana Lake, Sarah Noor, Mario E. Lacouture

Open Access Epidemiology

Evaluation of the international Ki67 working group cut point recommendations for early breast cancer: comparison with 21-gene assay results in a large integrated health care system

Veronica C. Shim, Robin J. Baker, Wen Jing, Roisin Puentes, Sally S. Agersborg, Thomas K. Lee, Wamda GoreaI, Ninah Achacoso, Catherine Lee, Marvella Villasenor, Amy Lin, Malathy Kapali, Laurel A. Habel

Epidemiology

The largest genome-wide association study for breast cancer in Taiwanese Han population

Yu-Ching Hsu, Hung-Lin Chen, Chi-Fung Cheng, Amrita Chattopadhyay, Pei-Shan Chen, Che-Chen Lin, Hsiu-Yin Chiang, Ting-Yuan Liu, Chi-Hao Huang, Chin-Chi Kuo, Eric Y. Chuang, Tzu-Pin Lu, Fuu-Jen Tsai

Epidemiology

Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus

Anna P. Sokolenko, Elvina Kh. Bakaeva, Aigul R. Venina, Ekaterina Sh. Kuligina, Alexandr A. Romanko, Svetlana N. Aleksakhina, Yana V. Belysheva, Evgeniya V. Belogubova, Ilya A. Stepanov, Olga A. Zaitseva, Olga S. Yatsuk, Alexandr V. Togo, Zaur M. Khamgokov, Azinat O. Kadyrova, Albert Sh. Pirmagomedov, Marina B. Bolieva, Alexandr A. Epkhiev, Aslan K. Tsutsaev, Madina D. Chakhieva, Khalimat M. Khabrieva, Idris M. Khabriev, Mirza A. Murachuev, Bella N. Buttaeva, Liliya S. Baboshkina, Fatima I. Bayramkulova, Islam R. Katchiev, Lina Kh. Alieva, Grigory A. Raskin, Sergey V. Orlov, Zarema K. Khachmamuk, Karine R. Levonyan, Dariya M. Gichko, Dmitriy V. Kirtbaya, Alexey M. Degtyariov, Luisa V. Sultanova, Hedi S. Musayeva, Alexey M. Belyaev, Evgeny N. Imyanitov

Epidemiology

National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial

Christine Rogers, Adrienne N. Cobb, Jan I. C. Lloren, Lubna N. Chaudhary, Morgan K. Johnson, Chiang-Ching Huang, Mediget Teshome, Amanda L. Kong, Puneet Singh, Chandler S. Cortina

Epidemiology

Characteristics, healthcare utilization, and outcomes of patients with HER2-low breast cancer

Devon K. Check, Bradford E. Jackson, Katherine E. Reeder-Hayes, Michaela A. Dinan, Eleanor Faherty, Jackie Kwong, Sandhya Mehta, Lisa Spees, Stephanie B. Wheeler, Lauren E. Wilson, Clara Lam

Open Access Epidemiology

The prognostic impact of BMI in patients with HR+/HER2− advanced breast cancer: a study of the SONABRE registry

Senna W. M. Lammers, Hannah Thurisch, Ingeborg J. H. Vriens, Marissa Meegdes, Sanne M. E. Engelen, Frans L. G. Erdkamp, M. Wouter Dercksen, Birgit E. P. J. Vriens, Kirsten N. A. Aaldering, Manon J. A. E. Pepels, Linda M. H. van de Winkel, Natascha A. J. B. Peters, Jolien Tol, Joan B. Heijns, Agnes J. van de Wouw, Nathalie J. A. Teeuwen, Sandra M. E. Geurts, Vivianne C. G. Tjan-Heijnen

Epidemiology

Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium

Mariana Brandão, Diogo Martins-Branco, Claudia De Angelis, Peter Vuylsteke, Richard D. Gelber, Nancy Van Damme, Lien van Walle, Arlindo R. Ferreira, Matteo Lambertini, Francesca Poggio, Didier Verhoeven, Annelore Barbeaux, Francois P. Duhoux, Hans Wildiers, Carmela Caballero, Ahmad Awada, Martine Piccart-Gebhart, Kevin Punie, Evandro de Azambuja

Open Access Original Laboratory Investigation

Hereditary cancer testing in a diverse sample across three breast imaging centers

Laura Westbrook, Darlene Miltenburg, Vivienne Souter, Melissa K. Maisenbacher, Katherine L. Howard, Youbao Sha, Maygol Yavari, Nicholas Kypraios, Angel Rodriguez, Jeffrey N. Weitzel

Original Laboratory Investigation

Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer

Meng Yue, Si Wu, Chang Liu, Lijing Cai, Xinran Wang, Ying Jia, Dandan Han, Yueping Liu

Original Laboratory Investigation

Rates of price disclosure associated with the surgical treatment of early-stage breast cancer one year after implementation of federal regulations

Shivani A. Shah, Yuqi Zhang, Arlene M. Correa, Baraa A. Hijaz, Alan Z. Yang, Oluwadamilola M. Fayanju, Marcelo Cerullo

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.